尊龙凯时
About us
尊龙凯时:Our Values
尊龙凯时:Development Milestone
Products
尊龙凯时:Product List for API
尊龙凯时:Recommended API
尊龙凯时:Product list for Chemicals and Intermediates
Product list for Chemicals and Intermediates
News
尊龙凯时:Contract Manufacturing
尊龙凯时:API and Pharmaceutical Intermediates
尊龙凯时:OTC and Generics
尊龙凯时:Investor Relation
尊龙凯时:PERIODIC REPORT
尊龙凯时:INTERIM REPORT
尊龙凯时:INVESTORS SERVICE
尊龙凯时:Contact Us
About us
News
尊龙凯时:Investor Relation
Products
尊龙凯时:Contract Manufacturing
尊龙凯时:Contact Us
Investor Relation
Investor Relation
PERIODIC REPORT
尊龙凯时:INTERIM REPORT
尊龙凯时:INVESTORS SERVICE
Revised Proxy Form for use at the Extraordinary General Meeting
2014-02-12
Revised Notice of Extraordinary General Meeting
2014-02-12
Monthly Return of Equity Issuer on Movements in Securities for the month ended 3
2014-02-07
SHAREHOLDER REPLY SLIP FOR THE EXTRAORDINARY GENERAL MEETING
2014-01-29
PROXY FORM FOR USE AT THE EXTRAORDINARY GENERAL MEETING
2014-01-29
NOTICE OF EXTRAORDINARY GENERAL MEETING
2014-01-29
Overseas Regulatory Announcement
2014-01-29
MAJOR AND CONNECTED TRANSACTION IN RELATION TO THE XINCAT PHARMACEUTICAL ACQUISI
2014-01-29
ANNOUNCEMENT
2014-01-29
POSITIVE PROFIT ALERT
2014-01-27
<
...
88
89
90
91
92
93
94
...
>
